Alex Pharma’s profits increase by 27.28% YoY in 6 months
Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 27.28% year-on-year (YoY) in net profit after tax in the first half (H1) of fiscal year (FY) 2022/2023, according to financial statements filed to the Egyptian Exchange (EGX) on February 5th.
The company’s net profit after tax jumped to EGP 72.957 million in the six-month period ended December 31st 2022 from EGP 57.318 million in the year-ago period.
Revenue jumped 35.67% YoY to EGP 783.16 million in the July-December period of 2022, up from EGP 577.26 million in the same period a year earlier.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.